Nutritional support in multimodal therapy for cancer cachexia

Supportive Care in Cancer

Volumn 16, Issue 5, 2008, Pages 447-451

  Bosaeus, Ingvar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anorexia; Body composition; Cachexia; Energy balance; Nutritional support

Indexed keywords

ERYTHROPOIETIN; INDOMETACIN; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANOREXIA; CACHEXIA; CALORIC INTAKE; CANCER PATIENT; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HYPERMETABOLISM; MALNUTRITION; MULTIMODALITY CANCER THERAPY; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUPPLEMENTATION;

ANOREXIA; ANTINEOPLASTIC AGENTS; CACHEXIA; ENERGY METABOLISM; HUMANS; NEOPLASMS; NUTRITIONAL SUPPORT; PROTEIN-ENERGY MALNUTRITION;

EID: 41849138323     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0388-7     Document Type: Review

References (34)

1. Baracos VE (2006) Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 26:435-461
2. Dewys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69(4):491-497
3. Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345-1350
4. Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L (1997) Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg 21:416-421
5. Skipworth RJ, Fearon KC (2007) The scientific rationale for optimizing nutritional support in cancer. Eur J Gastroenterol Hepatol 19:371-377
6. Tisdale MJ (1999) Wasting in cancer. J Nutr 129(1S Suppl):243S-246S
7. Kyle UG, Bosaeus I, De Lorenzo AD et al (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23(6):1430-1453
8. Baracos VE (2002) Hypercatabolism and hypermetabolism in wasting states. Curr Opin Clin Nutr Metab Care 5(3):237-239
9. Parkinson SA, Lewis J, Morris R, Allbright A, Plant H, Slevin ML (1987) Oral protein and energy supplements in cancer patients. Hum Nutr Appl Nutr 41(4):233-243
10. Levine JA, Morgan MY (1998) Preservation of macronutrient preferences in cancer anorexia. Br J Cancer 78:579-581
11. Staal-van den Brekel AJ, Schols AM, ten Velde GP, Buurman WA, Wouters EF (1994) Analysis of the energy balance in lung cancer patients. Cancer Res 54(24):6430-6433
12. Wigmore SJ, Plester CE, Ross JA, Fearon KC (1997) Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84(2):196-197
13. Cohn SH, Gartenhaus W, Vartsky D et al (1981) Body composition and dietary intake in neoplastic disease. Am J Clin Nutr 34:1997-2004
14. Simons JP, Schols AM, Hoefnagels JM, Westerterp KR, ten Velde GP, Wouters EF (1998) Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial. Cancer 82(3):553-560
15. Bosaeus I, Daneryd P, Svanberg E, Lundholm K (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93:380-383
16. Bosaeus I, Daneryd P, Lundholm K (2002) Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132:3465S-3466S
17. Warnold I, Lundholm K, Scherstén T (1978) Energy balance and body composition in cancer patients. Cancer Res 38:1801-1807
18. Bozzetti F, Pagnoni AM, Del Vecchio M (1980) Excessive caloric expenditure as a cause of malnutrition in patients with cancer. Surg Gynecol Obstet 150(2):229-234
19. Hyltander A, Drott C, Körner U, Sandström R, Lundholm K (1991) Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27(1):9-15
20. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL (1984) Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 53(6):1265-1273
21. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL (1983) Energy expenditure in malnourished cancer patients. Ann Surg 197(2):152-162
22. Barber MD, Ross JA, Fearon KC (1999) Cancer cachexia. Surg Oncol 8(3):133-141
23. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2(11):862-871
24. Zylicz Z, Schwantje O, Wagener DJ, Folgering HT (1990) Metabolic response to enteral food in different phases of cancer cachexia in rats. Oncology 47(1):87-91
25. Jatoi A, Daly BD, Hughes V, Dallal GE, Roubenoff R (1999) The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer 23(2):153-158
26. Jatoi A, Hillman S, Stella PJ et al (2003) Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer 11(7):460-464
27. Gibney E, Elia M, Jebb SA, Murgatroyd P, Jennings G (1997) Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46(12):1412-1417
28. Moses AW, Slater C, Preston T, Barber MD, Fearon KC (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996-1002
29. American College of Physicians (1989) Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 110(9):734-736
30. Lundholm K, Daneryd P, Körner U, Hyltander A, Bosaeus I (2004) Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24(3):505-512
31. Lundholm K, Gelin J, Hyltander A et al (1994) Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54(21):5602-5606
32. Lundholm K, Körner U, Gunnebo L et al (2007) Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699-2706
33. Lundholm K, Daneryd P, Bosaeus I, Körner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100(9):1967-1977
34. Shang E, Weiss C, Post S, Kaehler G (2006) The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer. J Parenter Enteral Nutr 30:222-230